Analyst Ratings for Regeneron Pharmaceuticals Inc. (REGN)

Updated: 2017-07-28

Analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) have given it a consensus rating of Overweight. A consensus rating of Overweight was previously issued for REGN last month.

Of the 24 analysts covering the stock, 10 gave it a buy rating, 1 issued an overweight rating, 13 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an decrease of 3 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

REGN was given price targets by several analysts. The maximum price target given was 593, implying a possible profit of 16.64 percent. The minimum price target given was 327, implying a possible loss of -35.68 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0.48 percent. The average change in earnings estimates over the last 90 days is -0.14 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0.39 percent. If we look at the last 90 days instead, we find a net average change of 0.77 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 1 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. During this time, 1 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

REGN has an estimated earnings growth rate of 24.83 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. REGN has a PEG ratio of 2.46.

REGN has traded between a high of 543.55 and a low of 325.35 over the past year. Today's price is 56.27 percent above the 52-week low, and below the high by 6.46 percent. REGN has a P/E ratio of 61.18. Investors typically compare the P/E ratio to a company's peers in the industry. The REGN value stock report compares REGN to some of its peers using value stock charts. The market cap of REGN is $54.81 billion. REGN's next earnings release will be on 0000-00-00, which is days away.